Florida / New York

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Akso Health Group Utilizes DeepSeek to Advance AI in Healthcare

Ms. Yilin (Linda) Wang , CEO of Akso Health Group stated, "The utilization of DeepSeek is a major milestone in AI powered healthcare. By leveraging DeepSeek's technological expertise, we aim to enhance diagnostic accuracy and deliver superior healthcare services to users worldwide."

Other News of Interest

Glytec Secures $36 Million Growth Investment to Accelerate AI-Powered Diabetes Technology Platform Innovation

This significant funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, accelerate the development of innovative new technologies to address the growing global health crisis of diabetes and related co-morbidities, and support the continued rapid response to upcoming CMS quality measures that will hold health systems accountable for inpatient glycemic control.

Akso Health Group (NASDAQ: AHG) (hereinafter referred to as “Akso Health,” “the Company,” or “we”) announced today its integration of DeepSeek’s advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry’s intelligent transformation.

As an innovative medical technology company, AHG leverages DeepSeek’s multimodal large-scale models, deep learning frameworks, and big data processing capabilities to upgrade its AI-powered diagnosis system. The upgraded system will integrate patient text descriptions, medical imaging, and laboratory test results, utilizing NLP and deep learning to provide more accurate diagnoses and personalized treatment recommendations. Additionally, DeepSeek’s model training framework helps AHG refine its AI models, enhancing diagnostic accuracy and response speed.

Furthermore, AHG will utilize DeepSeek to develop an AI-powered medical assistant to support doctors in retrieving patient records, analyzing similar cases, and recommending treatment plans, aiming to significantly improve diagnostic efficiency. AHG also incorporates human-centric AI interactions, ensuring a more natural and empathetic user experience, reducing patient anxiety, and optimizing the overall consultation experience.

Ms. Yilin (Linda) Wang , CEO of AHG stated, “The utilization of DeepSeek is a major milestone in AI powered healthcare. By leveraging DeepSeek’s technological expertise, we aim to enhance diagnostic accuracy and deliver superior healthcare services to users worldwide.”

Looking ahead, AHG will continue to explore AI applications in research and development, health management, and telemedicine, driving the healthcare industry toward a smarter and more efficient future.